Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
Shuang Qu,Xiaoli Huang,Xiaoling Guo,Zhihai Zheng,Tiannan Wei,Biyun Chen
DOI: https://doi.org/10.2147/DDDT.S415521
2023-06-06
Abstract:Shuang Qu, 1, &ast Xiaoli Huang, 2, &ast Xiaoling Guo, 3 Zhihai Zheng, 1 Tiannan Wei, 1 Biyun Chen 1 1 Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China; 2 Department of Clinical Laboratory Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China; 3 Translational Medicine Centre, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shuang Qu, Email Background: Acute myeloid leukemia (AML) is a highly heterogenous disease with varying clinical outcomes among patients. Epithelial-mesenchymal transition (EMT) is an important mechanism underlying cancer metastasis and chemotherapy resistance. However, few EMT-based signatures have been established to predict AML prognosis and treatment efficacy. Methods: By conducting comparative RNA-seq analysis, we discovered the differential expression of EMT genes between AML patients with relapse and those without relapse. Based on the prognostic analysis of the differentially expressed EMT genes, a metastasis-related EMT signature (MEMTs) was constructed. An analysis was conducted on both TARGET and TCGA cohorts to explore the possible association between MEMTs and prognosis in AML. Three separate chemotherapy treatment cohorts were utilized to assess the predictive efficacy of MEMTs for chemotherapy response. In addition, the potential correlation between MEMTs and the tumor microenvironment was also investigated. Finally, random forest analysis and functional experiments were conducted to verify the key MEMTs gene associated with AML metastasis. Results: Based on expression and prognostic analysis, we constructed MEMTs that include three EMT genes (CDH2, LOX, and COL3A1). Our findings suggested that the MEMTs could act as a prognostic factor for AML patients, and furthermore, it proved to be a predictor of their response to chemotherapy. Specifically, high MEMTs was associated with worse prognosis and poor response to chemotherapy, while low MEMTs was linked to better prognosis and higher response rates. Random forest and functional experiments demonstrate that CDH2 is a key gene promoting leukemia cell metastasis among the three MEMTs genes. Conclusion: The identification of MEMTs could potentially act as a predictor for the prognosis and the response to chemotherapy in AML patients. Individual tumor evaluation based on MEMTs could provide personalized treatment options for AML patients in the future. Keywords: acute myeloid leukemia, prognosis, metastasis, epithelial-mesenchymal transition, chemotherapy Acute Myeloid Leukemia (AML) is an intricate illness with diverse genetic alterations and heterogeneous clinical outcomes. 1–3 It is a highly aggressive malignancy that is associated with high relapse rates and poor overall survival outcomes. 4 Chemotherapy is an effective treatment for AML, but it is heterogeneous in its effectiveness. 5 While many patients with AML respond well to chemotherapy and achieve remission, others may have a poorer response or experience relapse despite treatment. This heterogeneity is likely due to the genetic and clinical diversity of AML, as well as the varying responses of individual patients to chemotherapeutic agents. 6–8 Therefore, there is a pressing need to create novel molecular markers that can precisely classify subtypes of AML patients who may derive greater benefits from specific treatment strategies. Epithelial-mesenchymal transition (EMT) is a biological phenomenon in which epithelial cells undergo a transformation and acquire mesenchymal characteristics, resulting in weakened cell-cell adhesion, enhanced motility, and invasiveness. 9–11 The importance of EMT in tumorigenesis and tumor advancement lies in its ability to facilitate cancer cell invasion into adjacent tissues and spread to distant locations. 12,13 Specifically, EMT facilitates the detachment of tumor cells from their primary site, as well as their migration into the circulatory system for eventual colonization in secondary organs. Moreover, EMT has been linked to drug resistance, immune evasion, and stem cell-like properties in cancer cells, further underscoring its impact on cancer pathogenesis. 14–20 Currently, there is a growing interest in developing prognostic models for cancer using EMT features. Recent studies have shown that EMT-related gene expression signatures can predict patient survi -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal